Cita APA

Neumann, A. U., Goekkaya, M., Dorgham, K., Traidl-Hoffmann, C., & Gorochov, G. (2021). Tocilizumab in COVID-19 therapy: Who benefits, and how? Lancet.

Citación estilo Chicago

Neumann, Avidan U., Mehmet Goekkaya, Karim Dorgham, Claudia Traidl-Hoffmann, y Guy Gorochov. "Tocilizumab in COVID-19 Therapy: Who Benefits, and How?" Lancet 2021.

Cita MLA

Neumann, Avidan U., et al. "Tocilizumab in COVID-19 Therapy: Who Benefits, and How?" Lancet 2021.